News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current SPHDF market cap is 147.62M. The company's latest EPS is CHF -5.6334 and P/E is -2.08.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 31.66M | 75.38M | 15.01M | -1.6M | 7.47M |
| Operating Income | -51.42M | -10.44M | -53.08M | -56.89M | -51.98M |
| Net Income | -54.19M | -18.97M | -67.66M | -55.53M | -71.08M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 110.29M | 115.05M | 88.69M | 91.12M | 63.73M |
| Total Liabilities | 82.47M | 93.8M | 95.04M | 89.79M | 107.41M |
| Total Equity | 27.83M | 21.25M | -6.35M | 1.33M | -43.69M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -37.87M | 2.6M | -43.51M | -37.36M | -29.84M |
| Investing | -5.91M | 2.79M | 1.56M | 69k | -3.93M |
| Financing | 20.64M | 4.13M | 23.15M | 46.02M | 13.99M |
| Market Cap | 147.62M |
| Price to Earnings Ratio | -2.08 |
| Price to Sales Ratio | 19.75 |
| Price to Cash Ratio | 109.14 |
| Price to Book Ratio | -3.38 |
| Dividend Yield | - |
| Shares Outstanding | 12.62M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 24.47% |
| 52 Week High | 13.35 |
| 52 Week Low | 9.40 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Santhera Pharmaceuticals Holdings Ltd (CE) |
| Address |
hammerstrasse 49 liestal 4410 |
| Website | https://www.santhera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
